Distinguishing itself from traditional telecom companies through its proactive strategies, BT has been part of several significant healthcare initiatives.
BT works closely with leading pharmaceutical companies, providing a range of key solutions that range from tackling counterfeiting to promoting patient and regulatory compliance. “BT Safety Chain uses autoID technology as a tracking mechanism to tackle counterfeiting of drugs across the supply chain,” notes Frost & Sullivan Research Analyst Paljit Sohal. “Currently, BT is providing pilots to customers that focus on biologics to track, trace and authenticate drugs.”
Patient compliance is a key challenge for pharma companies. BT's BT Vital Life monitors the compliance of patients with their drug regimes. This helps pharmas achieve increased compliance rates. BT is also working with several companies to enforce patient compliance during phase III clinical trials, especially in large trials covering over five thousand patients.
BT aims at helping organisations meet the challenges of regulatory compliance through effective information management, security, networks and business continuity planning. The company also has a regulatory compliance office that focuses on operation procedures, validation services, implementation and training, creating a key differentiation point for BT.
“Some of the projects and initiatives that BT has been involved in include delivering the world's largest e-health project in the world, 'connected for health',” states Sohal. “In addition, BT has been working with major pharma companies over the last decade, helping them outsource their enterprise communications.”
BT differentiates itself from traditional telecommunications companies by working in areas such as value creation and cost containment. Cost containment, for instance, is centered on outsourcing, where BT can leverage the fact that it is able to deliver services to multiple clients.
“In addition, traditional telecom companies do not focus on patient compliance,” adds Sohal. “BT works directly with top level management to discuss what the rates of non compliance (in areas such as diabetes, asthma, cancer and HIV and multiple sclerosis) are, investigates in which geographies particular solutions work best and how patients can be educated, among others.”
In essence, BT combines technology with a consulting approach. Rather than classical marketing, the company follows a solution-orientated approach. BT recognises the need for pharma companies to integrate into a global healthcare network and has worked towards this objective.
“BT meets the need of pharma companies to centre the healthcare ecosystem on patient requirements,” remarks Sohal. “BT is striving to ensure that pharma companies move away from the outmoded blockbuster approach towards a more sustainable business model.”
This Frost & Sullivan Global Excellence Customer Service Award is bestowed upon the company which has demonstrated global excellence in a given business function such as sales, marketing, customer service, technology innovation, product quality, supply chain management and growth strategy. Leveraging best practices in the company to all global units is a major metric that Frost & Sullivan utilises in its selection process. Frost & Sullivan, through this exhaustive selection process, seeks to identify a company that has exhibited global excellence in its operations, resulting in sustained financial growth. The Award recipient would have distinguished itself through its proactive global integration strategies that would position the company to emerge a global leader.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About BT Global Services
BT is one of the world's leading providers of communications solutions and services operating in 170 countries. Our principal activities include networked IT services, local, national and international telecommunications services, and higher-value broadband and internet products and services. BT consists principally of four lines of business: BT Global Services, Openreach, BT Retail and BT Wholesale.
BT Global Services (btglobalservices.com) helps multi-site organisations to master the complexity of business communication. It serves corporate and government customers worldwide, and wholesale customers outside the UK. It employs around 30,000 people in 50 countries and delivers service in 170 countries. In addition, BT Global Services has more than 10,000 professional services people (around 40 per cent of all its employees) skilled in business and process transformation, change and project management, solutions design and innovation. BT Global Services provides a range of specialist network-centric propositions and practices spanning high performance networking, applications management, outsourcing and managed services, and business transformation.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
BT Global Services
DDI: 001 771 107 3402